NLRP3 and synovial sarcoma: Notably, SS patients with established (or at high risk of) lymphoma exhibit high cfDNA levels, resulting in NLRP3 activation in circulating monocytes and NLRP3 activation and pyroptosis in macrophages infiltrating the salivary glands [169].